Cargando…
Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea
The coronavirus disease 2019 (COVID-19) continues to threaten public health in Korea although several surges have passed in the past 3 years since 2019. Although patients with mild-to-moderate COVID-19 can usually recover at home, antiviral therapy to prevent disease progression and hospitalization...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Medical Sciences
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745683/ https://www.ncbi.nlm.nih.gov/pubmed/36513054 http://dx.doi.org/10.3346/jkms.2022.37.e352 |